Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of ...

Were you SEEN at Rock Your Style, a fashion show featuring local "movers and shakers" to benefit the New York Oncology ...

These dedicated nursing roles can enhance care management of hospitalized patients undergoing radiotherapy and improve ...

Community Oncology Partners (COP), the owner-operator of medical oncology practices bringing the fight against cancer closer to home, today announced a partnership with House Rx, the leader in ...

Morgan Stanley analyst Judah Frommer maintained a Buy rating on Mural Oncology Plc (MURA – Research Report) yesterday and set a price ...

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development. The partnership ...

Citing fears of vertical integration and reduced competition, anti-monopoly advocacy group American Economic Liberties ...

Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on CG Oncology, Inc. (CGON – Research Report). The associated ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...

In today's healthcare environment, physicians face numerous challenges that significantly impact their professional lives and personal well-being. Among these, the complexities of electronic medical r ...

On Thursday, Pyxis Oncology Inc (PYXS) stock saw a modest uptick, ending the day at $3.72 which represents a slight increase of $0.21 or 5.98% from the prior close of $3.51. The stock opened at $3.52 ...